Danske Bank reports net profit of DKK 6.9 billion (EUR

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Danske Bank reports net profit of DKK 6.9 billion (EUR 920.0 million) for the first half of 2014
    To the editor   24 July 2014      

Danske Bank reports net profit of DKK 6.9 billion (EUR 920.0 million)

for the first half of 2014

Danske Bank has announced its financial results for the first half of 2014.

“We saw good progress in the first half of 2014,” says Thomas F. Borgen, CEO. “We increased net profit 88% from the level in the first half of 2013, and we are moving steadily in the right direction. Expenses are declining as expected,  the positive trend in impairments is continuing, and we saw growing customer activity in the second quarter of 2014.

The products and solutions we have launched have been well received by our customers, and they will continue to further strengthen our market position. Our progress thus far in 2014 shows that we are on track to create a more customer-focused, cost-effective and competitive bank.”

The report is available at danskebank.com. Highlights are shown below:

First half 2014 vs. first half 2013

  • In the first half of 2014, Danske Bank posted a profit before tax of DKK 8.6 billion (EUR 1,157.5 million). The net profit was DKK 6.9 billion (EUR 920.0 million). The net profit represents an increase of 88% from the level in the first half of 2013, driven by improvements in most income lines, lower expenses and lower impairments as well as a positive effect relating to the sale of our shareholding in Nets Holding A/S, which was divested on 9 July 2014.
  • The return on shareholders’ equity after tax was 9.2% p.a., against 5.2% p.a. for the first half of 2013. We are on track to reach our 2015 target.
  • Total income amounted to DKK 21.7 billion (EUR 2,912.1 million), rising 9% from the first half of 2013. Income rose because of the positive effect relating to Nets, the repayment of the hybrid capital raised from the Danish state in April, stronger customer activity and higher net income from insurance business.
  • Our focus on costs continued to produce savings according to plan. Expenses fell 6%, and the cost/income ratio improved to 50.8% from 59%.
  • At DKK 1.3 billion (EUR 169.9 million) impairments in our core activities remained low and benefited from improving macroeconomic conditions and credit quality.
  • The result of Non-core activities showed a loss before tax of DKK 0.8 billion (EUR 106.5 million). The result was in line with expectations, and the winding-up of our Non-core activities continues according to plan.
  • At the end of June 2014, total lending largely matched the level at the end of 2013. Most of Danske Bank’s markets saw weak growth and suppressed demand for credit. At the end of June 2014, total deposits were 2% below the level at the end of 2013.
  • At 30 June 2014, the common equity tier 1 capital ratio and the total capital ratio were 14.4% and 18.6%, respectively, against 14.7% and 21.4% at 31 December 2013. The repayment in April 2014 of the hybrid capital raised from the Danish state caused the ratios to fall, although the effect has been partially offset by a number of capital issues in 2013 and 2014. Our capital base thus remains very solid.

          With a liquidity coverage ratio of 133% at 30 June 2014, our liquidity position also remained strong.

Stronger net profit outlook

We expect net profit for 2014 to be in the range of DKK 10-13 billion (EUR 1,341-1,744 million). Our previous forecast was net profit at the higher end of a range of DKK 9-12 billion (EUR 1,207-1,610 million). The stronger outlook is owing mainly to improved developments in expenses and impairments as well as the positive effect relating to Nets.

Second quarter 2014 vs first quarter 2014

  • In the second quarter of 2014, profit before tax amounted to DKK 5.0 billion (EUR 670.6 million). Net profit was up 44% to DKK 4.0 billion (EUR 542.8 million).
  • Total income amounted to DKK 11.4 billion (EUR 1,525.9 million) and rose 10%. All income items contributed to the increase, including the positive effect relating to Nets.
  • As expected, expenses rose marginally from the first-quarter level. The increase was owing mainly to restructuring costs.
  • Impairments in core activities were largely the same as in the first quarter.

Danske Bank

Contacts:

Thomas F. Borgen, CEO, tel. +45 45 14 60 01

Henrik Ramlau-Hansen, CFO, tel. +45 45 14 06 66

More information about Danske Bank’s financial results is available at danskebank.com/reports.

This is a translation of a press release in the Danish language. In case of discrepancies, the Danish version prevails. Danish kroner translated into euros at an exchange rate of 1:7.4557.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 225

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 466

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 212

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 0

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 0

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 277

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 284

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 42

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading

Top 5 Most Recently Viewed Articles

Lawsuit Filed Alleging Eye Injury from Ozempic Use

Updated Category News Views 165

Parker Waichman LLP Takes Action Against Drug Manufacturer Parker Waichman, a prominent national law firm, is actively filing lawsuits for individuals who assert that they developed NAION after using Novo Nordisk's medications, Ozempic or Wegovy. The firm recently initiated a case for a Florida resident who experienced this severe eye condition after using Ozempic....

Continue Reading
C.H. Robinson Prepares for Upcoming Earnings Conference Call

Updated Category News Views 151

C.H. Robinson's Upcoming Earnings Release and Conference Call C.H. Robinson Worldwide, Inc. (Nasdaq: CHRW), a leading logistics provider, has announced significant plans for its upcoming earnings release. The company is scheduled to share its third quarter 2024 results post market close. On this important day, the company will hold a conference call to delve into the...

Continue Reading
PayPal Surges 14% After Exciting Partnership with OpenAI

Updated Category News Views 173

PayPal's Innovative Partnership with OpenAI Shares of PayPal Holdings Inc (NASDAQ: PYPL) experienced a notable increase of 14.38% in pre-market trading. This rise was sparked by the recent announcement of a deal between the payments giant and OpenAI. This partnership focuses on integrating PayPal's digital wallet into the popular AI platform, ChatGPT. Enabling...

Continue Reading
Unlocking the Future of Ridesharing: Uber and Nvidia's Game Changer

Updated Category News Views 199

Introduction to the Partnership In an exciting development, Uber Technologies Inc (NYSE: UBER) has announced a strategic partnership with Nvidia Corp (NASDAQ: NVDA) aimed at leveraging artificial intelligence (AI) to enhance ridesharing and autonomous vehicle technology. Analyst Justin Post from BofA Securities has enthusiastically maintained a Buy rating on Uber’s...

Continue Reading
Exploring the Future of Organic Infant Formula Market Growth

Updated Category News Views 275

Overview of Organic Infant Formula Market Growth The Organic Infant Formula market has seen remarkable expansion, indicating a shift in parental preferences towards health-conscious choices for their young ones. The market, which had a valuation of USD 20.8 billion in the recent past, is expected to reach an impressive USD 36.04 billion by 2032. This growth trajectory...

Continue Reading